Meidensha Corp
TSE:6508
Meidensha Corp
TSE:6508
Price:
4 340
JPY
-0.12%
Market Closed
Market Cap:
196.9B
JPY
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Meidensha Corp
4340
-5 (-0.12%)
| 52 Week Range |
2 390
4 345
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Meidensha Corp
Balance Sheet
Balance Sheet Decomposition
Meidensha Corp
Meidensha Corp
| Current Assets | 191.9B |
| Cash & Short-Term Investments | 23B |
| Receivables | 81.4B |
| Other Current Assets | 87.5B |
| Non-Current Assets | 122.3B |
| Long-Term Investments | 22.6B |
| PP&E | 74.6B |
| Intangibles | 7B |
| Other Non-Current Assets | 18.2B |
| Current Liabilities | 109.1B |
| Accounts Payable | 34B |
| Accrued Liabilities | 8.1B |
| Short-Term Debt | 6B |
| Other Current Liabilities | 61B |
| Non-Current Liabilities | 81.7B |
| Long-Term Debt | 25.6B |
| Other Non-Current Liabilities | 56.1B |
Balance Sheet
Meidensha Corp
Meidensha Corp
Currency: JPY
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
8 781
|
14 538
|
10 105
|
9 506
|
12 687
|
13 272
|
14 307
|
14 070
|
14 917
|
18 984
|
|
| Cash Equivalents |
8 781
|
14 538
|
10 105
|
9 506
|
12 687
|
13 272
|
14 307
|
14 070
|
14 917
|
18 984
|
|
| Total Receivables |
90 515
|
86 676
|
78 514
|
94 015
|
93 837
|
95 676
|
94 038
|
100 618
|
107 930
|
115 400
|
|
| Accounts Receivables |
90 515
|
86 676
|
78 514
|
94 015
|
93 837
|
95 676
|
94 038
|
100 618
|
107 930
|
112 837
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2 563
|
|
| Inventory |
39 030
|
38 980
|
40 104
|
41 724
|
42 648
|
43 204
|
43 855
|
50 714
|
58 738
|
67 223
|
|
| Other Current Assets |
8 751
|
8 563
|
8 856
|
4 210
|
4 559
|
4 406
|
4 983
|
5 892
|
6 166
|
6 896
|
|
| Total Current Assets |
147 077
|
148 757
|
137 579
|
149 455
|
153 731
|
156 558
|
157 183
|
171 294
|
187 751
|
208 503
|
|
| PP&E Net |
67 204
|
66 769
|
64 026
|
64 999
|
63 330
|
71 274
|
75 623
|
74 947
|
75 788
|
75 363
|
|
| PP&E Gross |
67 204
|
66 769
|
64 026
|
64 999
|
63 330
|
71 274
|
75 623
|
74 947
|
75 788
|
75 363
|
|
| Accumulated Depreciation |
94 562
|
98 230
|
102 536
|
107 211
|
111 174
|
116 973
|
121 421
|
130 520
|
135 489
|
142 454
|
|
| Intangible Assets |
5 449
|
6 381
|
6 599
|
6 917
|
6 563
|
6 216
|
6 366
|
6 293
|
5 787
|
5 475
|
|
| Goodwill |
1 037
|
1 145
|
1 055
|
5 738
|
4 645
|
3 976
|
3 210
|
3 272
|
2 675
|
2 175
|
|
| Note Receivable |
32
|
0
|
31
|
32
|
30
|
33
|
34
|
36
|
37
|
30
|
|
| Long-Term Investments |
23 920
|
19 640
|
26 886
|
21 719
|
20 149
|
14 104
|
19 482
|
17 132
|
16 696
|
26 558
|
|
| Other Long-Term Assets |
10 800
|
12 301
|
11 470
|
15 597
|
17 138
|
18 249
|
17 161
|
17 925
|
18 656
|
16 683
|
|
| Other Assets |
1 037
|
1 145
|
1 055
|
5 738
|
4 645
|
3 976
|
3 210
|
3 272
|
2 675
|
2 175
|
|
| Total Assets |
255 519
N/A
|
255 024
0%
|
247 646
-3%
|
264 457
+7%
|
265 586
+0%
|
270 410
+2%
|
279 059
+3%
|
290 899
+4%
|
307 390
+6%
|
334 787
+9%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
36 873
|
36 679
|
32 815
|
39 499
|
38 731
|
41 603
|
35 928
|
39 165
|
42 968
|
40 156
|
|
| Accrued Liabilities |
6 992
|
6 832
|
6 004
|
7 231
|
7 124
|
7 563
|
7 282
|
7 601
|
7 858
|
8 348
|
|
| Short-Term Debt |
20 127
|
16 262
|
20 391
|
12 060
|
6 838
|
8 699
|
11 176
|
11 727
|
14 411
|
18 649
|
|
| Current Portion of Long-Term Debt |
9 398
|
21 631
|
7 770
|
7 646
|
8 567
|
10 283
|
15 577
|
11 860
|
15 534
|
13 744
|
|
| Other Current Liabilities |
41 288
|
41 753
|
36 381
|
44 059
|
43 519
|
32 874
|
33 861
|
34 053
|
37 536
|
43 345
|
|
| Total Current Liabilities |
114 678
|
123 157
|
103 361
|
110 495
|
104 779
|
101 022
|
103 824
|
104 406
|
118 307
|
124 242
|
|
| Long-Term Debt |
26 772
|
15 441
|
22 850
|
26 417
|
30 087
|
34 225
|
28 393
|
32 443
|
28 425
|
30 092
|
|
| Deferred Income Tax |
0
|
43
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
1 296
|
1 239
|
1 075
|
995
|
777
|
3 005
|
3 201
|
3 455
|
2 983
|
3 081
|
|
| Other Liabilities |
46 602
|
47 612
|
47 116
|
46 316
|
46 223
|
45 046
|
47 106
|
48 629
|
49 777
|
50 965
|
|
| Total Liabilities |
189 410
N/A
|
187 492
-1%
|
174 409
-7%
|
184 223
+6%
|
181 866
-1%
|
183 298
+1%
|
182 524
0%
|
188 933
+4%
|
199 492
+6%
|
208 380
+4%
|
|
| Equity | |||||||||||
| Common Stock |
17 070
|
17 070
|
17 070
|
17 070
|
17 070
|
17 070
|
17 070
|
17 070
|
17 070
|
17 070
|
|
| Retained Earnings |
30 466
|
34 933
|
38 861
|
44 103
|
49 665
|
55 604
|
60 866
|
64 844
|
69 568
|
78 642
|
|
| Additional Paid In Capital |
13 197
|
13 197
|
13 197
|
12 435
|
11 923
|
11 402
|
10 927
|
10 474
|
10 211
|
10 226
|
|
| Unrealized Security Profit/Loss |
8 019
|
0
|
7 431
|
8 258
|
6 973
|
4 109
|
7 544
|
6 826
|
6 524
|
13 297
|
|
| Treasury Stock |
168
|
0
|
177
|
182
|
186
|
188
|
190
|
192
|
194
|
197
|
|
| Other Equity |
2 475
|
3 396
|
3 145
|
1 450
|
1 725
|
885
|
318
|
2 944
|
4 719
|
7 369
|
|
| Total Equity |
66 109
N/A
|
67 532
+2%
|
73 237
+8%
|
80 234
+10%
|
83 720
+4%
|
87 112
+4%
|
96 535
+11%
|
101 966
+6%
|
107 898
+6%
|
126 407
+17%
|
|
| Total Liabilities & Equity |
255 519
N/A
|
255 024
0%
|
247 646
-3%
|
264 457
+7%
|
265 586
+0%
|
270 410
+2%
|
279 059
+3%
|
290 899
+4%
|
307 390
+6%
|
334 787
+9%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
45
|
45
|
45
|
45
|
45
|
45
|
45
|
45
|
45
|
45
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
